Open-Label, Multicenter, Dose Escalation Phase 1b Study to Assess the Subcutaneous Delivery of Daratumumab in Patients (pts) with Relapsed or Refractory Multiple Myeloma (PAVO)
Year: 2016
Type: article
Source: Blood
Institutions: Carolinas Healthcare System, Levine Cancer Institute, Karolinska University Hospital, Karolinska Institutet, Instituto de Investigación Biomédica de Salamanca, Amsterdam UMC Location Vrije Universiteit Amsterdam, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Emory University, Winship Cancer Institute, Centre Hospitalier Universitaire de Nantes, Institut Català d'Oncologia, University of Southern Denmark, Vejle Sygehus, Centre Hospitalier Universitaire de Tours, Janssen (Belgium), Janssen Research & Development (United States), Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2601043525